Bristol-Myers Squibb Company (BMY)
Net profit margin
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 7,053,000 | -8,948,000 | 8,025,000 | 6,327,000 | 6,994,000 |
| Revenue | US$ in thousands | 48,194,000 | 48,300,000 | 45,006,000 | 46,159,000 | 46,385,000 |
| Net profit margin | 14.63% | -18.53% | 17.83% | 13.71% | 15.08% |
December 31, 2025 calculation
Net profit margin = Net income ÷ Revenue
= $7,053,000K ÷ $48,194,000K
= 14.63%
Peer comparison
Dec 31, 2025
Company name
Symbol
Net profit margin
Bristol-Myers Squibb Company
BMY
14.63%
AbbVie Inc
ABBV
6.91%
Amgen Inc
AMGN
20.98%
Biogen Inc
BIIB
13.18%
Eli Lilly and Company
LLY
31.66%
Gilead Sciences Inc
GILD
28.90%
Johnson & Johnson
JNJ
28.46%
Merck & Company Inc
MRK
28.08%
Organon & Co
OGN
3.01%
Pfizer Inc
PFE
12.42%